Zasadzińska, M. and Borowski, G. 2025. Semaglutide as a promising treatment for metabolic dysfunction‑associated steatotic liver disease. Journal of Medical Science. 94, 1 (Mar. 2025), e1219. DOI:https://doi.org/10.20883/medical.e1219.